[Differential drug therapy and prevention of different types of atrial fibrillation in ischemic heart disease patients].
Clinical and instrumental examination using enhanced atrial VCG and ECG in 140 patients with coronary heart disease complicated by frequent atrial fibrillation paroxysms (AFP) identified 3 types of atrial myocardial change: the "hemodynamic" or secondary atrial fibrillation, "arrhythmic", or primary atrial fibrillation, and "ischemic" ones, the former 2 types being particularly common. These pathogenetic differences taken into account, long-term differential therapy and prevention of AFP became possible where cordaron proved the most effective agent (74% response rate). Its effectiveness approached 83% in primary AFP and was somewhat lower (42%) in secondary AFP, while digoxin proved more efficient in the latter group (52%). Cordaron treatment was associated with a 9.2% side effects rate; low doses of the drug produced no side effects.